ARPA-H awards $125M for manufacturing custom RNA therapies on demand
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"ARPA-H awards $125M for manufacturing custom RNA therapies on demand" is generating significant coverage in the Business category, with 7 articles from 7 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Harvard Medical School, The Pharma Letter, pharmaphorum and Newswise. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 44d ago.
Quick answers
Why is "ARPA-H awards $125M for manufacturing custom RNA therapies on demand" trending?
Because 7 independent news sources published 7 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (7)
- ARPA-H Funds HMS-Led Pilot Project to Develop New Class of RNA Medicines Harvard Medical School · 47d ago
- ARPA-H backs five teams with $125m to make RNA meds on demand The Pharma Letter · 47d ago
- US puts $125m into personalised RNA therapy production pharmaphorum · 47d ago
- ARPA-H Funds HMS-Led Pilot Project To Develop New Class of RNA Medicines Newswise · 47d ago
- Waterfall Scientific Awarded $54.5 Mln To Lead Consortium For Cell-Free mRNA Manufacturing TradingView · 47d ago
- ARPA-H funds biotechs working on custom RNA therapies STAT · 47d ago
- ARPA-H awards $125M for manufacturing custom RNA therapies on demand Endpoints News · 47d ago
Topics
Related trends
Urine cell-free RNA for bladder cancer detection and treatment response prediction
Recent studies show a simple urine test analyzing cell-free RNA can detect bladder cancer and track treatment.
Structural basis of transcription of the hachimoji eight-letter alphabet by E. coli RNA polymerase
4 news sources are covering this Science story right now — PULSE is tracking how fast it spreads.
Scientists design new RNA therapy to bypass mutations behind thousands of genetic diseases
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
New lipid nanoparticle delivers capped circular RNA for longer-lasting gene expression
5 news sources are covering this Science story right now — PULSE is tracking how fast it spreads.
A ribozyme ligase that requires a 3′ terminal phosphate on its RNA substrate
A protein‑free ribozyme ligase that seeks out and repairs broken RNA reshapes ideas about early life and genome maintenance.
In a 3.5-billion-year-old clay-rich rock from Gale Crater, NASA’s Curiosity rover identified 21 carbon-based molecules — including a nitrogen-bearing ring structure linked to the chemistry that can precede RNA and DNA
7 news sources are covering this Science story right now — PULSE is tracking how fast it spreads.